Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02423044 · ClinicalTrials.gov registry record

Spatial Context and Fear Learning

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
82
Enrollment target

NCT02423044 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 82 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02423044 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
82 participants
Enrollment target

Study Summary

Background: \- Fear is a normal response to a threat. Learning fear can be helpful sometimes. For people with anxiety disorders, fear can be long-lasting and too intense. Researchers want to study how people become fearful of situations. They want to understand how the brain learns when it is helpful to feel fear and when it is not. Objective: \- To better understand brain processes related to fear and anxiety. Eligibility: * Right-handed adults ages 18 50 with generalized anxiety disorder, panic disorder, social anxiety disorder, or post-traumatic stress disorder. * Right handed volunteers ages 18-50 without psychiatric disorders. * And free of psychiatric medication for 2 weeks Design: * Participants will first be screened under another protocol. * Participants will play a video game inside a magnetic resonance imaging (MRI) scanner. The scanner is a metal cylinder It is surrounded by a strong magnetic field. Participants will lie on a table that can slide in and out of the scanner. A device called a coil will be placed over the head. * During the scan, participants may play a virtual reality video game. Game instructions will be explained before they enter the scanner. * While playing the game, participants will wear 2 electrodes on their fingers. These measure sweat on the skin. They will also have 2 small electrodes attached to the left hand. These can give brief mild electrical shocks. * Participants will be asked questions when playing the game during the scan. * Before and after the scan, participants will fill out questionnaires about their emotions. They may complete questionnaires online while at the clinic.

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2015-04-18
Est. Completion 2018-10-30

What the Registry Record Tells You About NCT02423044

The ClinicalTrials.gov registry entry for NCT02423044 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02423044 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02423044 about?

NCT02423044 is a clinical study titled "Spatial Context and Fear Learning". Background: \- Fear is a normal response to a threat. Learning fear can be helpful sometimes. For people with anxiety disorders, fear can be long-lasting and too intense. Researchers want to study how people become fearful of situations. They want to understand how the brain learns when it is helpf...

What is the current status of trial NCT02423044?

This trial is currently completed. The enrollment target is 82 participants. The study started on 2015-04-18. Estimated completion is 2018-10-30.

Who is sponsoring clinical trial NCT02423044?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.